Albany Molecular Research, Inc. (NASDAQ:AMRI)
| CAPS Rating |
|
|---|---|
| Open | $2.98 |
| Previous Close | $2.99 |
| Daily Range | $2.90 - $3.04 |
| 52-Week Range | $2.08 - $5.55 |
| Market Cap | $90.03M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 54,832 |
| Average Daily Volume | 0 |
AMRI
VS S&P 500 (SPY)
How do you think AMRI will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
AMRI Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
AMRI News and Commentary
- Registration Effectiveness Orders Issued By The SEC – SmartMoney
- 6 Stocks The Street is Buying – Blog at The Motley Fool
- The AMRI Rocket Ship – Blog at The Motley Fool
- Future Biotech Superstars – SeekingAlpha
- Our Investor Outlook: Cautious and Protected – SeekingAlpha
- UPDATE: Dr Reddy's Gets US Court OK To Sell Generic Allegra D-24 – SmartMoney
- Sifting Through the Rubble of 2010: 9 Beaten Up, Deep-Value Small Caps – SeekingAlpha
- Value Opportunities Created by Mutual Fund Selling – SeekingAlpha
- How Cheap Is Teva? – The Motley Fool
- Analyst Calls: AMAT, AMRI, BP, BUCY, DB, FDO, GS, ISIL, THO ... – BloggingStocks
- UPDATE 1-Albany Molecular seeks injunction against Dr Reddy's – Reuters
- 5 Stocks Ready for Liftoff – The Motley Fool
- 7 Surprising 1-Star Stocks – The Motley Fool
- Wall Street's Wish List – The Motley Fool
- Albany Molecular Plays the Odds – The Motley Fool
- Albany Molecular Bouncing Back – The Motley Fool
- IBM Goes Back to School – The Motley Fool
- Albany Molecular Stabilizes – The Motley Fool
- Albany Molecular's Royalty Squeeze – The Motley Fool
- Albany Molecular's Mixed Bag – The Motley Fool
RSS Headlines
Fool UK
